Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults

BACKGROUND: Pharmacokinetic and safety data on stimulants in older adults are limited. The objective of this study was to characterize the pharmacokinetics of lisdexamfetamine dimesylate (LDX), a d-amphetamine prodrug, in older adults. METHODS: In this two-period crossover trial, healthy adults (n =...

Descripción completa

Detalles Bibliográficos
Autores principales: Ermer, James, Haffey, Mary B, Richards, Cynthia, Lasseter, Kenneth, Adeyi, Ben, Corcoran, Mary, Stanton, Beverly, Martin, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575217/
https://www.ncbi.nlm.nih.gov/pubmed/23431065
http://dx.doi.org/10.2147/NDT.S38377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575217/
https://www.ncbi.nlm.nih.gov/pubmed/23431065
http://dx.doi.org/10.2147/NDT.S38377

Ejemplares similares